tiprankstipranks
Trending News
More News >

PainChek Partners with Eldermark to Enhance US Market Presence

Story Highlights
PainChek Partners with Eldermark to Enhance US Market Presence

Don’t Miss TipRanks’ Half-Year Sale

PainChek Ltd ( (AU:PCK) ) has shared an announcement.

PainChek Ltd has entered into a reseller and integration agreement with Eldermark Software LLC to expand its reach in the US long-term care market. This partnership will integrate PainChek’s AI-powered pain assessment tools into Eldermark’s care management systems, aiming to improve pain management accuracy and enhance resident care. The collaboration is a strategic move for PainChek as it anticipates FDA clearance, potentially impacting its market positioning and offering significant benefits to stakeholders in the care sector.

More about PainChek Ltd

PainChek Ltd is a company that develops smartphone-based pain assessment and monitoring applications. Their primary product is a regulatory-cleared medical device that enables best-practice pain management for individuals who cannot reliably self-report their pain. The company operates globally, with regulatory clearance in multiple regions including Australia, Canada, the European Union, and others, and is currently seeking FDA clearance in the United States.

Average Trading Volume: 1,241,599

Technical Sentiment Signal: Buy

Current Market Cap: A$90.25M

See more insights into PCK stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1